Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.

about

Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.

Item

http://www.wikidata.org/entity/Q52687765

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@en

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@nl

type

Item

label

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@en

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@nl

prefLabel

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@en

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@nl

P1476

Thyrotoxicosis and Adrenocorti ...... atment for Malignant Melanoma.

@en

P2093

Hidefumi Inaba

http://www.w3.org/2001/XMLSchema#string

Hiroshi Iwakura

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Ariyasu

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yamaoka

http://www.w3.org/2001/XMLSchema#string

Naotaka Doi

http://www.w3.org/2001/XMLSchema#string

Takashi Akamizu

http://www.w3.org/2001/XMLSchema#string

Takayuki Ota

http://www.w3.org/2001/XMLSchema#string

Yasushi Furukawa

http://www.w3.org/2001/XMLSchema#string

Yuki Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Autoimmune hypophysitis.

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Isolated acquired ACTH deficiency and primary hypothyroidism: a short series and review.

Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.

Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies

Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.

Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.

P304

345-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11244

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29475919

http://www.w3.org/2001/XMLSchema#string

P932

5905204

http://www.w3.org/2001/XMLSchema#string